MDPI

Several Scientific Journals Publish Research by Herbalife Scientists Highlighting Global Product Testing Standards

Retrieved on: 
Monday, April 24, 2023
Research, Vitamins, Supplements, Other Retail, Fitness & Nutrition, Specialty, General Health, Health, Retail, Science, Other Science, Taste, Multiplex polymerase chain reaction, Validation, Herbal medicine, Direct electron ionization liquid chromatography–mass spectrometry interface, Composition, Integrated DNA Technologies, Patent Cooperation Treaty, Spectrometry, Chinese University of Hong Kong, PCT, Quality, Open access, Food industry, Walker Process Equipment, Inc. v. Food Machinery & Chemical Corp., Patent, Manuscript, MDPI, Master of Science, Medicine, Open Access Scholarly Publishing Association, Quality assurance, Control, Education minister, Accuracy and precision, Content, Safety, Dietary supplement, Book, Standardization, Herbalife, Food

Premier wellness company and community, Herbalife, announced today that five recent research studies by its team of Quality Assurance scientists have been published across several international peer-reviewed journals.

Key Points: 
  • Premier wellness company and community, Herbalife, announced today that five recent research studies by its team of Quality Assurance scientists have been published across several international peer-reviewed journals.
  • The articles share the company’s best practices in validating herbal ingredients, identifying compound sampling techniques and other processes involved in the rigorous testing that goes into Herbalife products around the world.
  • The acceptance and publication of these studies underscore the global nutrition company’s commitment to scientific research, transparency, and accountability, driving consumer confidence and helping people live their best lives.
  • Herbalife products, quality assurance and manufacturing processes have received numerous international awards attesting to its high-quality standards.

Review Highlights Growing Evidence That PharmaJet’s Precision Delivery Devices Improve Nucleic Acid Vaccine Performance

Retrieved on: 
Thursday, February 23, 2023
Biotechnology, Pharmaceutical, Health, Medical Devices, Stratis, Tissue, Safety, HIV, Orthohantavirus, University of Cape Town, Vaccine (journal), DNA, University, Antigen, Bureau of Oceans and International Environmental and Scientific Affairs, Molecular medicine, Injection, Infection, Cell, Use, MDPI, Trial of the century, Subcutaneous tissue, TROPI, Therapy, Probability, Human, Drugs Controller General of India, Multimedia, Messenger, Vaccine, COVID-19, RNA

(Graphic: Business Wire)

Key Points: 
  • (Graphic: Business Wire)
    The COVID-19 pandemic increased visibility of nucleic acid vaccines, such as messenger RNA (mRNA), that provide scalability and can be quickly adapted as new variants appear.
  • Historical limitations can be addressed with new administration technologies such as modern needle-free precision delivery systems.
  • “We currently have eighty-three studies ongoing with novel pharmaceuticals focusing on nucleic acid technology in addition to other new vaccine technology platforms.
  • We believe that our precision delivery devices have the potential to increase the performance and therefore probability of regulatory success of many of these candidate vaccines.”
    Refer to Instructions for Use to ensure safe injections and to review risks.

ProPhase Labs Esophageal Cancer Early Detection Test (BE-smart) Featured in Peer-Reviewed Article in the International Journal of Molecular Science

Retrieved on: 
Thursday, February 16, 2023
Biomarker, Mayo Clinic, Prophase, Oncogene, Carcinogenesis, Protein, Molecular biology, Clinical professor, LDT, Biotechnology, HIV disease progression rates, Hyperkinesia, Canadian International Council, MDPI, Cell, Research, International Journal of Molecular Sciences, Translation, Outline of health sciences, Cancer, Esophageal cancer, Proteomics, Growth, Genomics, Western University, Medical imaging, Mittal

The article highlights the current clinical limitations and future molecular innovations of Barrett’s esophagus-related cancer.

Key Points: 
  • The article highlights the current clinical limitations and future molecular innovations of Barrett’s esophagus-related cancer.
  • Dr. Agrawal is the Director of Research & Biotechnology and Professor in Translational Research at Western University of Health Sciences.
  • Dr. Abdo has over a decade of experience researching molecular oncology mechanisms in gastrointestinal diseases and has published dozens of peer-reviewed articles on esophageal cancer.
  • In the coming weeks, we plan to further update our shareholders as to our progress and development timelines for our BE-Smart Esophageal Cancer Test.

REGENATIVE LABS ANNOUNCES UPDATES ON RETROSPECTIVE STUDY OF WHARTON'S JELLY APPLICATIONS TO THE KNEE

Retrieved on: 
Monday, February 20, 2023
OA, Knee, Pain, VAS, WOMAC, Arthropathy, Regenerative endodontics, MDPI, Visual analogue scale, Osteoarthritis, Birth control

PENSACOLA, Fla., Feb. 20, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces updates to its 2022 MDPI retrospective study on tissue defects in and around the knee.

Key Points: 
  • PENSACOLA, Fla., Feb. 20, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces updates to its 2022 MDPI retrospective study on tissue defects in and around the knee.
  • Last August, Regenative announced its preliminary retrospective observations on Wharton's Jelly applications to the knee.
  • Regenative is recruiting doctors now to take part in a prospective study regarding the efficacy of Wharton's Jelly in knee joint applications.
  • "This is really just the beginning to the potential benefits and uses of tissue allografts," said Regenative Labs CEO, Tyler Barrett.

Clarivate Adds Preprint Citation Index to the Web of Science

Retrieved on: 
Thursday, February 9, 2023
German Chemical Society, Product management, Organization, ArXiv, ChemRxiv, CLVT, Clarivate, Yale University, Cold Spring Harbor Laboratory, Chemical Society of Japan, Citation, Social Science Research Network, Royal, RSC, NYSE, Web of Science, Economics, Mathematics, CSJ, Journal Citation Reports, Chemical Society, MDPI, MedRxiv, Database, Research, ACS, Statistics, BMJ, CCS, Intelligence, Preprint, Physics, Partnership, Chemistry, Royal Society, BioRxiv, American Chemical Society, Publishing, Information technology, Pharmaceutical industry

LONDON, Feb. 9, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, has added the Preprint Citation Index™ to the Web of Science™ platform. Researchers can now locate and link to preprints alongside other trusted content in the database, to streamline the research process and help make meaningful connections faster.

Key Points: 
  • At launch, the Preprint Citation Index provides nearly two million preprints from the arXiv, bioRxiv, chemRxiv, medRxiv, and Preprints.org repositories.
  • The Preprint Citation Index enables users to:
    Locate versions of record (where applicable) for preprints: Find and reference peer-reviewed articles with links from preprints to Web of Science Core Collection records.
  • Connect preprints to journal articles: Uncover connections between cutting-edge preprints indexed in the Preprint Citation Index and journal articles indexed in the Web of Science Core Collection via citation linking.
  • We've created the Preprint Citation Index to support faster, more complete research, through the lens of the trusted high-quality content for which the Web of Science is known."

Clarivate Adds Preprint Citation Index to the Web of Science

Retrieved on: 
Thursday, February 9, 2023
German Chemical Society, Product management, Organization, ArXiv, ChemRxiv, CLVT, Clarivate, Yale University, Cold Spring Harbor Laboratory, Chemical Society of Japan, Citation, Social Science Research Network, Royal, RSC, NYSE, Web of Science, Economics, Mathematics, CSJ, Journal Citation Reports, Chemical Society, MDPI, MedRxiv, Database, Research, ACS, Statistics, BMJ, CCS, Intelligence, Preprint, Physics, Partnership, Chemistry, Royal Society, BioRxiv, American Chemical Society, Publishing, Information technology, Pharmaceutical industry

LONDON, Feb. 9, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, has added the Preprint Citation Index™ to the Web of Science™ platform. Researchers can now locate and link to preprints alongside other trusted content in the database, to streamline the research process and help make meaningful connections faster.

Key Points: 
  • At launch, the Preprint Citation Index provides nearly two million preprints from the arXiv, bioRxiv, chemRxiv, medRxiv, and Preprints.org repositories.
  • The Preprint Citation Index enables users to:
    Locate versions of record (where applicable) for preprints: Find and reference peer-reviewed articles with links from preprints to Web of Science Core Collection records.
  • Connect preprints to journal articles: Uncover connections between cutting-edge preprints indexed in the Preprint Citation Index and journal articles indexed in the Web of Science Core Collection via citation linking.
  • We've created the Preprint Citation Index to support faster, more complete research, through the lens of the trusted high-quality content for which the Web of Science is known."

Global Medical Publishing Market to Grow by $1.7 Billion During 2023-2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 13, 2023
Health, Other Health, American Medical Association, Wolters Kluwer, IBM, BMJ (company), Elsevier, Kirtsaeng v. John Wiley & Sons, Inc., MDPI, Research, OA, Massachusetts Medical Society, Informa, Risk management, Retail

This study identifies the transition toward OA publication model as one of the prime reasons driving the medical publishing market growth during the next few years.

Key Points: 
  • This study identifies the transition toward OA publication model as one of the prime reasons driving the medical publishing market growth during the next few years.
  • The report on the medical publishing market covers the following areas:
    The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading medical publishing market vendors that include American Medical Association, Athenahealth Inc., Australian Medical Association Ltd., BMJ Publishing Group Ltd., Charlesworth Publishing Services Ltd, Crimson Interactive Pvt.
  • Also, the medical publishing market analysis report includes information on upcoming trends and challenges that will influence market growth.
  • The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Portland State University, PAX and True Terpenes Partner to Develop First-of-its-Kind Open Source Cannabis Framework for Safety Evaluation

Retrieved on: 
Tuesday, January 3, 2023
Science, Public Policy, Government, Other Science, Research, Natural Resources, White House, Federal Government, State, Local, Cannabis, PAX, European Menopause and Andropause Society, Hope, MDPI, Environment, Health, Terpene, Safety, Policy, Cannabis, Doctor of Philosophy, Research, Perfume, Risk management, Drug, Toxicology

However, there is little science-based guidance for consumers, manufacturers, or regulators to evaluate the safety of additives in cannabis concentrates.

Key Points: 
  • However, there is little science-based guidance for consumers, manufacturers, or regulators to evaluate the safety of additives in cannabis concentrates.
  • Ultimately, it aims to increase safety standards across the cannabis industry and, most importantly, reduce consumer risk.
  • However, the federal status of the scheduling of cannabis and divergence across state regulations have created challenges for state-licensed cannabis manufacturers.
  • As the cannabis industry develops, regulators and cannabis manufacturers alike need actionable methods for toxicological risk assessment of inhalable cannabis concentrate additives.

Multiplex Assay Market Size, Share & Trends Analysis Report 2022: Companion Diagnostics benefitting from Increasing Applications of Multiplex Assays - ResearchAndMarkets.com

Retrieved on: 
Friday, December 16, 2022
Health, Biotechnology, Immunotherapy, R, Consumables, American Cancer Society, Diagnosis, Degenerative disease, Medicine, Flow cytometry, Cipla, SWOT analysis, Prevalence, RA, Hospital, Cancer, MDPI, Conditional sentence, Neurodegeneration, PCR, Toxicity, USD, Luminex, Infection, Growth, Research, Disease, Biomarker, Automation, COVID-19, Patient, Politics, UTI, LabCorp, Medical device, Renewable energy, Pharmaceutical industry, Vaccine, Software, Rheumatoid arthritis

The "Multiplex Assay Market Size, Share & Trends Analysis Report by Product (Consumables, Software), by Application (R&D, Clinical Diagnostics), by Type, by Technology, by End-user, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Multiplex Assay Market Size, Share & Trends Analysis Report by Product (Consumables, Software), by Application (R&D, Clinical Diagnostics), by Type, by Technology, by End-user, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • Multiplex assay aids in the diagnosis of cancer and reduces unnecessary invasive producers.
  • Thus, growing chronic diseases can boost the necessity of these assays and is anticipated to fuel market growth.
  • Furthermore, the advantages of multiplex assay over singleplex and traditional assay can boost the industry growth in coming years.

SCiFi Foods Conducts World's First Sustainability Study of Cultivated Beef Products Proving Climate Benefit Claims

Retrieved on: 
Thursday, December 15, 2022
Water, MDPI, Sustainability, Parity, Science, Life-cycle assessment, Smell, Sustainability (journal), Research, LCA, Climate, OSU, FDA, Peer review, Policy, Journal, BoxGroup, News, Engineering, CRISPR, SAN, Ohio State University, Science Publishing Group, Bachelor of Engineering, Medical device, Agriculture, San Francisco Bay Area

SAN FRANCISCO, Dec. 15, 2022 /PRNewswire-PRWeb/ -- In a year that has seen a tremendous amount of exciting news around cultivated meat, SCiFi Foods, brings yet another major milestone to the space. The Bay Area startup, which has quickly become a leading name since emerging from stealth just six months ago, announced today the results of the first Life Cycle Analysis (LCA) ever conducted around the sustainability benefits of cultivated beef products. The study, conducted by The Ohio State University (OSU), was further validated by Sustainability, a peer-reviewed, open-access academic journal published by MDPI, who, after a lengthy analysis, ultimately approved and published the study. Currently, it is available for all to read online, free of charge.

Key Points: 
  • Until now, there have been limited research to prove such claims, however, none specifically conducted around cultivated beef, which has opened the door to some criticism.
  • As such, SCiFi Foods felt it was important to prove the validity of its sustainability assertions.
  • The LCA environmental impact study took a SCiFi burger consisting of cultivated beef cells and plant-based ingredients (water, soy protein isolate, etc.)
  • SCiFi Foods is racing to be first to market in cultivated beef with the launch of the SCiFi burger.